ATE448317T1 - Verfahren zur herstellung von alpha- glycosylisoquercitrin, zugehörige zwischenstufe sowie nebenprodukt - Google Patents

Verfahren zur herstellung von alpha- glycosylisoquercitrin, zugehörige zwischenstufe sowie nebenprodukt

Info

Publication number
ATE448317T1
ATE448317T1 AT04773224T AT04773224T ATE448317T1 AT E448317 T1 ATE448317 T1 AT E448317T1 AT 04773224 T AT04773224 T AT 04773224T AT 04773224 T AT04773224 T AT 04773224T AT E448317 T1 ATE448317 T1 AT E448317T1
Authority
AT
Austria
Prior art keywords
gum
sodium
isoquercitrin
glycosylisoquercitrin
gelatin
Prior art date
Application number
AT04773224T
Other languages
English (en)
Inventor
Masamitsu Moriwaki
Kazuhiro Emura
Hisashi Tanaka
Original Assignee
San Ei Gen Ffi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Ei Gen Ffi Inc filed Critical San Ei Gen Ffi Inc
Application granted granted Critical
Publication of ATE448317T1 publication Critical patent/ATE448317T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/41—Retaining or modifying natural colour by use of additives, e.g. optical brighteners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT04773224T 2003-09-29 2004-09-10 Verfahren zur herstellung von alpha- glycosylisoquercitrin, zugehörige zwischenstufe sowie nebenprodukt ATE448317T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003338689 2003-09-29
PCT/JP2004/013580 WO2005030975A1 (ja) 2003-09-29 2004-09-10 α－グリコシルイソクエルシトリン、並びにその製造中間体及び副生成物の調製方法

Publications (1)

Publication Number Publication Date
ATE448317T1 true ATE448317T1 (de) 2009-11-15

Family

ID=34386169

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04773224T ATE448317T1 (de) 2003-09-29 2004-09-10 Verfahren zur herstellung von alpha- glycosylisoquercitrin, zugehörige zwischenstufe sowie nebenprodukt

Country Status (8)

Country Link
US (1) US7691425B2 (de)
EP (1) EP1669462B1 (de)
JP (1) JP4498277B2 (de)
KR (1) KR101086441B1 (de)
CN (1) CN100413975C (de)
AT (1) ATE448317T1 (de)
DE (1) DE602004024097D1 (de)
WO (1) WO2005030975A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007125578A1 (ja) * 2006-04-27 2007-11-08 Noevir Co., Ltd. 保湿剤、美白剤及び痩身剤
JP6145021B2 (ja) * 2006-09-22 2017-06-07 三栄源エフ・エフ・アイ株式会社 高甘味度甘味料の呈味改善方法
JP5447754B2 (ja) * 2006-09-22 2014-03-19 三栄源エフ・エフ・アイ株式会社 高甘味度甘味料の呈味改善方法
ES2347119B2 (es) * 2009-04-22 2011-04-28 Universidad De Santiago De Compostela Nanocapsulas de poliarginina.
JP5985229B2 (ja) * 2012-04-11 2016-09-06 花王株式会社 難水溶性ポリフェノール類の糖付加物の製造方法
WO2017094910A1 (ja) * 2015-12-04 2017-06-08 三栄源エフ・エフ・アイ株式会社 酵素処理イソクエルシトリンの利用
JP6873667B2 (ja) * 2015-12-04 2021-05-19 三栄源エフ・エフ・アイ株式会社 唾液分泌促進剤
JP6873668B2 (ja) * 2015-12-04 2021-05-19 三栄源エフ・エフ・アイ株式会社 経口組成物用添加剤
JP7011649B2 (ja) * 2017-04-12 2022-02-10 サントリーホールディングス株式会社 ステビア由来ラムノース合成酵素及び遺伝子
CN107119086B (zh) * 2017-05-27 2021-12-21 华南理工大学 一种基于黑曲霉细胞催化芦丁水解制备异槲皮苷的方法
CN110462052A (zh) 2017-07-28 2019-11-15 太阳化学株式会社 黄酮包合化合物的制造方法
TWI761672B (zh) * 2018-04-23 2022-04-21 日商阿爾卑斯藥品工業股份有限公司 O-醣苷基類黃酮之組成物
EP3805399A4 (de) * 2018-06-01 2022-03-09 Taiyo Kagaku Co., Ltd. Zusammensetzung mit flavonoid-cyclodextrin-clathrat-verbindung
CN109438536A (zh) * 2018-10-29 2019-03-08 广东金骏康生物技术有限公司 一种异槲皮素及其衍生物的应用与制备方法
US10617705B1 (en) 2019-01-24 2020-04-14 Alps Pharmaceutical Ind. Co., Ltd. Isoquercitrin compositions
US10918654B1 (en) 2019-09-23 2021-02-16 Alps Pharmaceutical Ind. Co., Ltd. Rutin compositions
US11110109B2 (en) 2019-10-22 2021-09-07 Alps Pharmaceutical Ind. Co., Ltd. Water soluble O-glycosyl flavonoid compositions and methods for preparing same
CN116609444B (zh) * 2022-10-09 2025-08-12 厦门市燕之屋丝浓生物科技有限公司 食品中增稠剂海藻酸钠含量的测定方法
CN115976140A (zh) * 2022-12-27 2023-04-18 南京安佰思生物科技有限公司 一种酶改性异槲皮素的生产制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727223D0 (en) 1987-11-20 1987-12-23 Unilever Plc Preparing l-rhamnose
JPH01213293A (ja) 1988-02-22 1989-08-28 San Ei Chem Ind Ltd 水易溶性フラボノール配糖体の製法
JP2898019B2 (ja) * 1989-08-21 1999-05-31 三栄源エフ・エフ・アイ株式会社 水難溶性フラボノイドの溶解方法
JP3510717B2 (ja) * 1995-09-29 2004-03-29 三栄源エフ・エフ・アイ株式会社 活性酸素・フリーラジカル消去活性を有する飲食品
JP3155466B2 (ja) * 1996-07-03 2001-04-09 東洋精糖株式会社 水溶性ケルセチン配糖体含有物およびその製造方法
DE19850029A1 (de) 1998-10-30 2000-05-04 Merck Patent Gmbh Verfahren zur enzymatischen Spaltung von Rutinosiden
JP2006502712A (ja) * 2002-09-23 2006-01-26 ハー マジェスティ ザ クイーン イン ライト オブ カナダ，アズ レプレゼンティッド バイ ザ ミニスター オブ アグリカルチャー 植物バイオマス由来フラボノイドの抽出、精製、及び変換

Also Published As

Publication number Publication date
EP1669462B1 (de) 2009-11-11
US7691425B2 (en) 2010-04-06
JPWO2005030975A1 (ja) 2006-12-07
CN100413975C (zh) 2008-08-27
KR20060096425A (ko) 2006-09-11
WO2005030975A1 (ja) 2005-04-07
EP1669462A4 (de) 2008-10-08
KR101086441B1 (ko) 2011-11-25
EP1669462A1 (de) 2006-06-14
US20080187622A1 (en) 2008-08-07
CN1860239A (zh) 2006-11-08
JP4498277B2 (ja) 2010-07-07
DE602004024097D1 (de) 2009-12-24

Similar Documents

Publication Publication Date Title
ATE448317T1 (de) Verfahren zur herstellung von alpha- glycosylisoquercitrin, zugehörige zwischenstufe sowie nebenprodukt
WO2007079458A3 (en) Protein hydrolysates and method of making
WO2012155295A8 (zh) 一种工业化生产玉米降压活性肽的方法
Honda et al. Alpha-glutelin degradation and its hydrolysate by protease enhance the specific volume of gluten-free rice starch bread
JP2011512124A5 (de)
WO2004036982A3 (en) Shrimp and the production thereof
EP2446892A3 (de) Isolierte adulte pluripotente Stammzellen und Verfahren zu deren Isolierung und Kultivierung
ATE493502T1 (de) Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse
MX2009004992A (es) Sustancia que contiene proteinas con estabilidad termica incrementada.
CN102227170A (zh) 水解的蛋白质-多糖复合物
EP4305969A1 (de) Flüssige eierersatzzusammensetzung und hitzekoagulierte substanz
KR20140143315A (ko) 혼합 단백분해효소 처리된 콩단백을 포함하는 식물성 고기의 제조방법 및 이를 이용한 콩불고기
BRPI0510972A (pt) método para produzir alimento animal, método para aumentar a capacidade de passagem pelo rúmen de uma ração animal e alimento animal
CN114568679A (zh) 一种素肉香精及其制备方法
EP4305968A4 (de) Verfahren zur herstellung eines proteinabbauprodukts und enzympräparat
MX2021005071A (es) Hidrolizados de proteina de maiz y metodos para elaborarlos.
WO2023172739A3 (en) Method for producing novel plant-based whole cut meat analogue
TW200621170A (en) 5'-ribonucleotide-rich yeast extract and its production
WO2004090094A3 (de) L-carnitin dehydrogenasen, deren derivate und ein verfahren zur herstellung von substituierten (s)-alkanolen
CN111557386A (zh) 综合利用鱼类下脚料制备猫粮诱食剂的方法
CN104323300A (zh) 牛骨酶解法
WO2018187389A3 (en) THIOESTERASE VARIANTS HAVING IMPROVED ACTIVITY FOR THE PRODUCTION OF MEDIUM CHAIN FATTY ACID DERIVATIVES
MY198027A (en) Oral/enteral vegetarian food compositions and method of manufacturing the same
ATE491346T1 (de) Verfahren zur herstellung von wirkstoffextrakten aus sojabohnen und entsprechende anwendungen der hergestellten extrakte
DE60140961D1 (de) Verfahren zur herstellung eines hochwertigen eiweisshydrolisats

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties